September 2026
The global cell to body market size was evaluated at USD 17.60 billion in 2026 and is predicted to hit around USD 58.61 billion by 2035, growing at a CAGR of 14.30%.
September 2026
The autologous stem cell and non-stem cell based therapies market size stood at USD 10.75 billion in 2026, with major autologous stem cell and non-stem cell based therapies market companies including Vericel Corporation, Holostem Terapie Avanzate, Anterogen Co. Ltd., BrainStorm Cell Therapeutics.
September 2026
The cellular vehicle-to-everything (C-V2X) market reached USD 2.22 billion in 2026, with prominent companies such as Qualcomm Technologies Inc., Huawei Technologies Co., Ltd., Intel Corporation leading the cellular vehicle-to-everything (C-V2X) market.
September 2026
The body contouring devices market size was estimated at USD 2.29 billion in 2026 and is projected to be worth around USD 7.44 billion by 2035, with a CAGR of 14.04%.
September 2026
The global cell cycle inhibitors market size was evaluated at USD 6.13 billion in 2026 and is predicted to hit around USD 11.50 billion by 2035, growing at a CAGR of 7.23%.
September 2026
The global image-based cytometry in cell analysis market size is accounted to hit around USD 9.78 billion by 2035 increasing from USD 4.06 billion in 2026, with a CAGR of 10.27%.
September 2026
The global automotive fuel cell market size is estimated at USD 14.29 billion in 2026 and is expected to hit around USD 289.49 billion by 2035, growing at a CAGR of 39.90% from 2026 to 2035.
September 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 1,127.65 million in 2026, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
September 2026
The hematopoietic stem cell transplantation market size reached USD 12.69 billion in 2026, with leading hematopoietic stem cell transplantation market companies including Novartis, Gilead Sciences, Baxter International, Fresenius Kabi.
September 2026
The global custom antibody market reached USD 232.14 billion in 2026, featuring leading custom antibody companies such as GenScript, LifeSpan BioSciences, Inc, Labcorp Drug Development, Abmart.
August 2026
The global antibody drug conjugates market size is projected to hit around USD 34.80 billion by 2035 from USD 12.69 billion in 2025 with a soild CAGR of 10.61%.
July 2026
The global CAR T-cell therapy market size is calculated at USD 5,206.15 million in 2025 and is projected to surpass around USD 26,982.3 million by 2035 with a solid CAGR of 17.88%.
July 2026
The global automated cell counter market size was evaluated at USD 6.84 billion in 2024 and is predicted to surpass around USD 11.77 billion by 2034 with a CAGR of 5.58%.
July 2026
The global single-cell omics market size is projected to hit around USD 45.28 billion by 2035 from USD 6.19 billion in 2025 with a CAGR of 22.02%.
July 2026
The global cell dissociation market size was reached at USD 710 million in 2025 and is expected to hit around USD 2,433 million by 2035 with a CAGR of 13.11%.
June 2026
The global extracellular vesicles-based liquid biopsy market size is evaluated at USD 122.72 million in 2025 and is predicted to hit around USD 152.88 million by 2035, growing at a CAGR of 2.47%.
June 2026
The global cellulose-reinforced hydrogels market size is evaluated at USD 1.44 billion in 2025 and is predicted to hit around USD 2.78 billion by 2035, growing at a CAGR of 6.80%.
June 2026
The global engineered TCR (T-Cell Receptor) therapy market is growing as immunotherapies advance for cancer and infectious disease treatment.
June 2026
The global T-cell immunotherapy market size is estimated to hit around USD 29.45 billion by 2035 increasing from USD 8.43 billion in 2025, with a CAGR of 13.33%.
June 2026
The global cell therapy manufacturing market size was valued at USD 5.55 billion in 2025 and is projected to hit around USD 21.02 billion by 2035 with a CAGR of 14.24%.
June 2026
The U.S. stem cell therapy market size reached USD 6.75 billion in 2025 and is projected to hit around USD 21.31 billion by 2035 with a remarkeble CAGR of 12.18%.
May 2026
The global automated and closed cell therapy market size is estimated to hit around USD 12.9 billion by 2035 increasing from USD 1.86 billion in 2025, with a CAGR of 21.37%.
May 2026
The cell expansion market size was evaluated at USD 22.14 billion in 2025 and is predicted to surpass around USD 67.46 billion by 2035, growing at a CAGR of 11.79%.
May 2026
The cell separation market size was exhibited at USD 14.15 billion in 2025 and is estimated to hit around USD 47.14 billion by 2035, growing at a solid CAGR of 12.79%.
May 2026
The global 3D cell culture market size accounted for USD 2.12 billion in 2025 and it is expected to hit around USD 7.87 billion by 2035 with a CAGR of 14.02%.
April 2026
The cellular health screening market size was valued at USD 3.73 billion in 2025 and is expected to hit around USD 7.98 billion by 2035 at a CAGR of 7.90%.
April 2026
The global carboxymethyl cellulose market size was valued at USD 4.37 billion in 2025 and is projected to attain around USD 19.04 billion by 2035 with a CAGR of 4.32%.
April 2026
The autologous cell therapy market size was garnered at USD 11.43 billion in 2025 and is expected to hit around USD 60.03 billion by 2035 With a CAGR of 18.04%.
February 2026
The global cell line development market size surpassed USD 6.39 billion in 2025 and is projected to reach around USD 15.85 billion by 2035 with a notable CAGR of 9.51%.
February 2026
The global cell-based assays market size is projected to hit around USD 44.23 billion by 2035 from USD 19.78 billion in 2025 with a CAGR of 8.38%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com